A Study to Investigate Safe and Tolerable Dose of GMA301 Injection in Healthy Volunteers
Clinical trial NCT04505137 · COMPLETED
Trial details
- NCT number
- NCT04505137
- Sponsor
- Gmax Biopharm Australia Pty Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-02
- Primary completion
- 2021-03-19
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.